HLscience Co. Ltd (239610) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.023x

Based on the latest financial reports, HLscience Co. Ltd (239610) has a cash flow conversion efficiency ratio of -0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.01 Billion ≈ $-1.36 Million USD) by net assets (₩87.36 Billion ≈ $59.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 239610 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

HLscience Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how HLscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

HLscience Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HLscience Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Catena Media plc
ST:CTM
0.055x
Vow Green Metals AS
OL:VGM
-0.030x
Greggs PLC
LSE:GRG
0.221x
Nanologica AB
ST:NICA
-0.064x
Ziga Innovation Public Company Limited
BK:ZIGA
-0.012x
Burcon NutraScience Corporation
TO:BU
0.640x
Indara Insurance Public Company Limited
BK:INSURE
0.071x
Lammhults Design Group AB (publ)
ST:LAMM-B
-0.029x

Annual Cash Flow Conversion Efficiency for HLscience Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of HLscience Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see HLscience Co. Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩94.54 Billion
≈ $64.07 Million
₩-3.59 Billion
≈ $-2.43 Million
-0.038x -99.23%
2023-12-31 ₩102.59 Billion
≈ $69.53 Million
₩-1.96 Billion
≈ $-1.33 Million
-0.019x -150.22%
2022-12-31 ₩104.22 Billion
≈ $70.63 Million
₩3.95 Billion
≈ $2.68 Million
0.038x -61.45%
2021-12-31 ₩107.26 Billion
≈ $72.69 Million
₩10.56 Billion
≈ $7.16 Million
0.098x -36.97%
2020-12-31 ₩95.84 Billion
≈ $64.95 Million
₩14.97 Billion
≈ $10.14 Million
0.156x -40.67%
2019-12-31 ₩81.21 Billion
≈ $55.04 Million
₩21.38 Billion
≈ $14.49 Million
0.263x +27.35%
2018-12-31 ₩62.99 Billion
≈ $42.69 Million
₩13.02 Billion
≈ $8.82 Million
0.207x +88.26%
2017-12-31 ₩53.14 Billion
≈ $36.01 Million
₩5.83 Billion
≈ $3.95 Million
0.110x -0.29%
2016-12-31 ₩50.19 Billion
≈ $34.01 Million
₩5.53 Billion
≈ $3.75 Million
0.110x -48.47%
2015-12-31 ₩14.53 Billion
≈ $9.85 Million
₩3.10 Billion
≈ $2.10 Million
0.214x -5.19%
2014-12-31 ₩10.26 Billion
≈ $6.95 Million
₩2.31 Billion
≈ $1.57 Million
0.225x --

About HLscience Co. Ltd

KQ:239610 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$20.23 Million
₩29.84 Billion KRW
Market Cap Rank
#25096 Global
#1796 in Korea
Share Price
₩5860.00
Change (1 day)
-0.17%
52-Week Range
₩5430.00 - ₩12310.00
All Time High
₩105342.87
About

HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen's pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr. Green Propolis, morosil diet fit, skin master secret, enerlinger vitamin D, PS300 formulated by doctor, Skin Master P-estro, and Dr. Prebiot… Read more